View in EDS HTML Full Text PDF Full Text

Favorable Rates of Cardiovascular Events with Stringent Cardiovascular Monitoring and a Lowered Dose of Ponatinib as Second-Line Treatment in Chronic Phase Chronic Myeloid Leukemia Patients Failing or Intolerant to First-Line Second-Generation Tyrosine Kinase Inhibitor Treatment: Results of the Prospective PONS Trial

Saved in:
Bibliographic Details
Title: Favorable Rates of Cardiovascular Events with Stringent Cardiovascular Monitoring and a Lowered Dose of Ponatinib as Second-Line Treatment in Chronic Phase Chronic Myeloid Leukemia Patients Failing or Intolerant to First-Line Second-Generation Tyrosine Kinase Inhibitor Treatment: Results of the Prospective PONS Trial
Authors: le Coutre, Philipp1 (AUTHOR), Burchert, Andreas2 (AUTHOR), Saußele, Susanne3 (AUTHOR), Schwarzer, Thekla1 (AUTHOR), Stintzing, Sebastian1 (AUTHOR), Pelzer, Uwe1 (AUTHOR), Bullinger, Lars1 (AUTHOR), Elmaagacli, Ahmet4 (AUTHOR), Jehn, Christian1,3 (AUTHOR), Stegelmann, Frank5 (AUTHOR), Hochhaus, Andreas6 (AUTHOR), Ernst, Thomas6 (AUTHOR), Göthert, Joachim R.7 (AUTHOR)
Source: Acta Haematologica. 2026, Vol. 149 Issue 3, p355-362. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 194303878
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Favorable Rates of Cardiovascular Events with Stringent Cardiovascular Monitoring and a Lowered Dose of Ponatinib as Second-Line Treatment in Chronic Phase Chronic Myeloid Leukemia Patients Failing or Intolerant to First-Line Second-Generation Tyrosine Kinase Inhibitor Treatment: Results of the Prospective PONS Trial
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22le+Coutre%2C+Philipp%22">le Coutre, Philipp</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Burchert%2C+Andreas%22">Burchert, Andreas</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Saußele%2C+Susanne%22">Saußele, Susanne</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Schwarzer%2C+Thekla%22">Schwarzer, Thekla</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Stintzing%2C+Sebastian%22">Stintzing, Sebastian</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pelzer%2C+Uwe%22">Pelzer, Uwe</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bullinger%2C+Lars%22">Bullinger, Lars</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Elmaagacli%2C+Ahmet%22">Elmaagacli, Ahmet</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jehn%2C+Christian%22">Jehn, Christian</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Stegelmann%2C+Frank%22">Stegelmann, Frank</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hochhaus%2C+Andreas%22">Hochhaus, Andreas</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ernst%2C+Thomas%22">Ernst, Thomas</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Göthert%2C+Joachim+R%2E%22">Göthert, Joachim R.</searchLink><relatesTo>7</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Acta+Haematologica%22">Acta Haematologica</searchLink>. 2026, Vol. 149 Issue 3, p355-362. 8p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=194303878
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1159/000545826
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 8
        StartPage: 355
    Titles:
      – TitleFull: Favorable Rates of Cardiovascular Events with Stringent Cardiovascular Monitoring and a Lowered Dose of Ponatinib as Second-Line Treatment in Chronic Phase Chronic Myeloid Leukemia Patients Failing or Intolerant to First-Line Second-Generation Tyrosine Kinase Inhibitor Treatment: Results of the Prospective PONS Trial
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: le Coutre, Philipp
      – PersonEntity:
          Name:
            NameFull: Burchert, Andreas
      – PersonEntity:
          Name:
            NameFull: Saußele, Susanne
      – PersonEntity:
          Name:
            NameFull: Schwarzer, Thekla
      – PersonEntity:
          Name:
            NameFull: Stintzing, Sebastian
      – PersonEntity:
          Name:
            NameFull: Pelzer, Uwe
      – PersonEntity:
          Name:
            NameFull: Bullinger, Lars
      – PersonEntity:
          Name:
            NameFull: Elmaagacli, Ahmet
      – PersonEntity:
          Name:
            NameFull: Jehn, Christian
      – PersonEntity:
          Name:
            NameFull: Stegelmann, Frank
      – PersonEntity:
          Name:
            NameFull: Hochhaus, Andreas
      – PersonEntity:
          Name:
            NameFull: Ernst, Thomas
      – PersonEntity:
          Name:
            NameFull: Göthert, Joachim R.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 00015792
          Numbering:
            – Type: volume
              Value: 149
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Acta Haematologica
              Type: main
ResultId 1